Author:
Krishnatreyya Harshita,Hazarika Hemanga,Das Bhrigu Kumar,Gogoi Neelutpal,Ahmed Abdul Baquee,Zaman Kamaruz
Publisher
Springer International Publishing
Reference130 articles.
1. Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, Hoenen T, Feldmann H, Schnittler H-J. Ebola virus enters host cells by macropinocytosis and Clathrin-mediated endocytosis. J Infect Dis. 2011;204:S957–67. https://doi.org/10.1093/infdis/jir326.
2. Alvarez CP, Lasala F, Carrillo J, Muñiz O, Corbí AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol. 2002;76:6841–4. https://doi.org/10.1128/JVI.76.13.6841-6844.2002.
3. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun. 2014;55:1–9. https://doi.org/10.1016/j.jaut.2014.09.001.
4. Antoine TE, Hadigal SR, Yakoub AM, Mishra YK, Bhattacharya P, Haddad C, Valyi-Nagy T, Adelung R, Prabhakar BS, Shukla D. Intravaginal zinc oxide tetrapod nanoparticles as novel immunoprotective agents against genital herpes. J Immunol. 2016;196:4566–75. https://doi.org/10.4049/jimmunol.1502373.
5. Arizona State University. Origins of world’s first cure for Ebola had roots at ASU [WWW Document]; 2019. https://biodesign.asu.edu/news/origins-world’s-first-cure-ebola-had-roots-asu#:~:text=Therootsoftheamazing,producetheEbola therapeuticZMapp.&text=AsofAug. Accessed 31 Jan 2022.